• Confronting the Challenges in Keeping Trials on Track

    Clinical Research News | A top scientific leader at Merck issued a call to action to stakeholders in the clinical research enterprise at last week’s SCOPE event, inviting them to focus on what’s important to the real-world people they’re looking to treat and clearly answering the questions being asked by people holding anti-science views.

    Feb 17, 2026

  • Pharma’s AI Adoption: Learning From Other Technology Adoptions

    Clinical Research News | At the recent SCOPE Venture, Innovation, and Partnering Conference in Orlando, healthcare veteran Carolyn Magill, Venture Partner at Defined Ventures, sat down with Sunny Kumar, Partner at Informed Ventures, to discuss a pressing question facing the pharmaceutical industry: How can pharma harness the transformative power of artificial intelligence while navigating its traditionally risk-averse culture?

    Feb 13, 2026

  • The Scope of Things: Tackling the Problematic Trio with Joseph Kim

    Clinical Research News | Clinical trials have always struggled with the problematic trio: study execution, patient recruitment, and engagement. In the newest episode of The Scope of Things, Joseph Kim, chief strategy officer of ProofPilot, spoke about the reason why these problems have still not been solved, despite repeated attempts.

    Feb 12, 2026

  • EverythingALS Advances a New Clinical Research Model for ALS Trials

    Clinical Research News | Clinical research in amyotrophic lateral sclerosis has long been hindered by subjective endpoints, slow enrollment, and limited tools for tracking disease progression. EverythingALS, a nonprofit initiative, is addressing those barriers with a speech-based digital biomarker designed to modernize how ALS trials are conducted and evaluated.

    Feb 11, 2026

  • AI’s Promise Hinges on Redesigning Workflows

    Clinical Research News | The promise of AI was on full display at last week’s SCOPE event in Orlando, peppering each of hundreds of presentations focused on the future of clinical research. Analysts have projected that AI in clinical trials will represent an $8 billion business segment by 2030, generating up to $110 billion per year in value to pharma, but that will not happen unless the workflows are redesigned.

    Feb 10, 2026

  • SCOPE 2026: And The Winners Are…

    Clinical Research News | SCOPE 2026 kicked off in Orlando this week honoring XX groups with awards recognizing their technical innovations and creative work in service of patients and sites. The honored groups were Biogen, Proximity Health Solutions, TrialScreen, The Association of Multisite Research Corporations (AMRC), and new product awards for Biorce, ZigZag, Medidata, Innovative Trials, and Anju.

    Feb 5, 2026

  • Hope: A Tricky Concept for Trial Participants With Rare Conditions

    Clinical Research News | ORLANDO—For patients with a rare disease participating in clinical trials, hope can be a “doubled-edged sword,” potentially saving their lives but also burdening them with enormous, if unintended, hidden costs. Hope is also their “trust in us” as they desperately search for restorative treatments like chimeric antigen receptor (CAR) T-cell therapy, Jane Myles told a packed house during the opening day plenary keynote address at this week’s SCOPE event in Orlando.

    Feb 3, 2026

  • SCOPE 2026: AI in Clinical Research Poised for Boom Times

    Clinical Research News | An assortment of new product launches, funding news, and leadership appointments were announced in conjunction with this week’s SCOPE event in Orlando, which is experiencing a record-breaking attendance exceeding 4,800 people. The announcements serve as a potent reminder that artificial intelligence is having a field day in clinical research, and the common aim is right sizing the time and cost of getting medicines to market.

    Feb 3, 2026

  • SCOPE 2026 Best of Show Entries

    Clinical Research News | SCOPE is kicking off this week and among all of the other events, speakers, and awards programs planned, the Best of Show awards again brings an impressive docket of new products to the SCOPE exhibit hall floor with a record-breaking 70 new products on display in Orlando.

    Feb 2, 2026

  • Follow the Money: Using AI for Clinical Enrollment, Pan-KRAS Degrader Trial, MoreBy Clinical Research Staff

    Clinical Research News | Mendra aims to employ AI to accelerate patient identification and clinical trial enrollment; PAQ Therapeutics will advance its ongoing Phase 1 development of PT0253, PAQ's KRAS G12D degrader; and more.

    Jan 28, 2026

  • Mount Sinai Connects Cancer Patients with Trials, Molecular Testing in Sub-Saharan Africa, Medable Announces TMF Agent

    Clinical Research News | The Mount Sinai Tisch Cancer Center has launched a new artificial intelligence platform; Cytespace expanded its molecular testing capabilities to meet rising demand across Sub-Saharan Africa; Medable announced its TMF Agent; and more.

    Jan 27, 2026

  • ESG Is Becoming a Clinical Operations Accountability

    Clinical Research News | Clinical operations leaders are being asked to deliver faster, more complex trials while carrying Environmental, Social, and Governance (ESG) commitments they do not directly control. That tension is no longer theoretical. As supplier sustainability performance becomes a material driver of execution risk, quality, and delivery speed, ESG is quietly shifting from a corporate reporting obligation to a clinical operations accountability.

    Jan 26, 2026

  • Why Clinical Trial Operations is the Place to Start with AI

    Clinical Research News | Clinical trials are foundational to all breakthrough therapies, yet they are mired in operational quicksand—particularly study startup inefficiencies. According to WCG’s 2025 Site Challenges Report, nearly one-third of respondents ranked study startup issues around contracts, budgets, and system builds as the leading problem slowing clinical trials while nearly 20% cite trial financial management (payments) as a topmost burden.

    Jan 23, 2026

  • How Smartwatches are Advancing Sleep Measurement

    Clinical Research News | Artificial intelligence (AI) is reshaping how clinical researchers study sleep, which has been tested with either simple self-reporting sleep logs or cumbersome sleep studies that take place in a lab or clinic. A new AI-driven sleep-staging framework called BIDSleep was developed at the University of Massachusetts Amherst.

    Jan 20, 2026

  • Closing the Research Gap in Africa Through Decentralized Patient Engagement and Remote Trial Models

    Clinical Research News | Africa remains one of the most important yet underleveraged regions in global drug development. The continent carries a substantial share of disease burden but contributes only a small fraction of clinical trial activity. This imbalance is not driven by scientific limitations or lack of patient interest. It reflects structural constraints that traditional site centric trial models have failed to overcome at scale.

    Jan 16, 2026

  • A Stronger, More Disciplined Future for Emerging Biopharma

    Clinical Research News | With the close of 2025 came the end of a prolonged biotech winter marked by reduced funding, massive job cuts, investor skepticism, and initial public offering slowdown. The experience, while painful, helped mature the biopharma industry with operational discipline and a new playbook for how to make the case with investors moving forward.

    Jan 13, 2026

  • New In-Ear EEG Platform Opens Door to Real-World Neurological Data Collection

    Clinical Research News | A newly FDA-cleared in-ear electroencephalogram (EEG) device could significantly alter how neurological conditions are studied, screened, and monitored outside traditional clinical settings. Paris-based Naox Technologies announced at CES 2026 in Las Vegas that its medical-grade Naox Link system has received U.S. Food and Drug Administration 510(k) clearance.

    Jan 12, 2026

  • The Scope of Things: Raising the Bar for Evidence Generation in Clinical Research

    Clinical Research News | As clinical research faces mounting pressure to generate real-world evidence faster and more efficiently, non-interventional studies may be a useful tool to achieve this. Yet, they have been historically underutilized.

    Jan 8, 2026

  • Trendspotting: Embracing AI, DEI Changes, Restrategizing Research Sites

    Clinical Research News | To kick off 2026, we spoke with industry experts and leaders in the Clinical Research News community about what they expect and look forward to in the new year. More than ever before, artificial intelligence took center stage.

    Jan 6, 2026

  • Top Stories of 2025: AI in Clinical Research, Pharmacy Recruitment, Pragmatic Trials

    Clinical Research News | In clinical research, AI was the hottest topic this year, with the Food & Drug Administration, big pharma, and researchers exploring ways generative AI can help with drug discovery, the clinical trials process, and the regulatory landscape. But clinical trials are still a personal venture, and other stories topped the list highlighting the person-to-person interaction necessary for trial success.

    Dec 29, 2025